Preliminary Experience in Ultra-High Frequency Ultrasound Assessment of Cutaneous Primary Lymphomas: An Innovative Classification
Author:
Russo Anna1, Patanè Vittorio1ORCID, Gagliardi Federico1, Urraro Fabrizio1ORCID, Ronchi Andrea2, Vitiello Paola3, Sica Antonello1, Argenziano Giuseppe3ORCID, Nardone Valerio1ORCID, Reginelli Alfonso1ORCID
Affiliation:
1. Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, Italy 2. Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, 80138 Naples, Italy 3. Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, Italy
Abstract
Background: Primary cutaneous lymphoma (PCL) is a rare form of extranodal non-Hodgkin’s lymphoma characterized by malignant lymphocytes confined to the skin. Accurate diagnosis and staging are crucial for optimal management, yet radiological literature on imaging PCL remains limited. This study aims to delineate the imaging characteristics of PCLs using high and ultra-high frequency ultrasound (UHFUS) and proposes a classification system based on ultrasound findings. Methods: A cohort of 88 individuals with suspected PCL underwent high-resolution ultrasound (HRUS) and color Doppler examination of lesions. Lesions were categorized based on sonographic appearance, and subsequent histopathological assessment confirmed the diagnosis. Results: Ultrasound imaging revealed distinct patterns for primary cutaneous T-cell lymphomas (PCTCL) and primary cutaneous B-cell lymphomas (PCBCL), with characteristic features such as hypoechoic nodules, pseudonodular lesions, and dermal infiltration. Histopathological analysis confirmed the ultrasound findings, supporting the proposed classification system. Conclusions: Ultrasonography, particularly UHFUS, offers valuable insights into the imaging characteristics of primary cutaneous lymphomas, aiding the accurate diagnosis and assessment of treatment response. The proposed classification system based on ultrasound findings enhances the diagnostic approach to PCLs, and paves the way for improved patient care and management strategies.
Reference31 articles.
1. A Comprehensive Update of the Atypical, Rare and Mimicking Presentations of Mycosis Fungoides;Lebas;Dermatol. Ther.,2021 2. Sonego, B., Ibatici, A., Rivoli, G., Angelucci, E., Sola, S., and Massone, C. (2023). Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas. Cells, 12. 3. Roccuzzo, G., Giordano, S., Fava, P., Pileri, A., Guglielmo, A., Tonella, L., Sanlorenzo, M., Ribero, S., Fierro, M.T., and Quaglino, P. (2021). Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives. Front. Oncol., 11. 4. Dermoscopy of primary cutaneous B-cell lymphoma (PCBCL);Piccolo;J. Am. Acad. Dermatol.,2016 5. Primary cutaneous lymphoma: Recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC;Olsen;Blood,2022
|
|